Lagan, Romeo F.
HRN: 28-45-59 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/17/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/17/2026
03/24/2026
IV
500
Q8
Amoebiasis
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: